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Few studies have so far focused on paternity in CF. Hence, an observational
retrospective study on CF men who experienced paternity between 1977 and 2010
was performed among ten CF Centres in Italy.
Data on paternity were reported in 65 CF men (mean age at CF diagnosis 22.1 yrs
(±15, range 0−57), who fathered a total of 94 children (mean 1.47 [range 1−4]
child/father). Pregnancies were achieved by natural conception (NC) in 20% (13),
Medical Assisted Procreation (MAP) with donor semen in 7.7% (5), MAP with
man’s own semen in 53.8% (35). The mean age at 1st paternity was 34.8 yrs.
Paternity increased (4.6% in 1970−80s, 20% in 1990s and 73.8% in the ﬁrst
decade of 2000) and modality changed over time. In the 1970−80s there were
only 3, all by NC. In the following years NC remained stable (15.4% in the 1990s,
14.6% in 2000−10), while MAP by own semen increased (38.5% in 1990s vs
62.5% in 2000−10). Adoption were 38.5% in the 1990s and 14.6% in 2000−10.
63.6% of MAP were performed in the town/region of residence, 24.2% in a different
Italian region, 12.1% abroad. MAP was successful at the 1st cycle in 36%, at the
2nd in 32%, and more than 3 cycles were necessary in 32%. Twin pregnancies
were 11 (17%; 1 by NC, 10 after MAP). Three babies were affected by CF (these
pregnancies were by NC and fathers were diagnosed as CF after fathering). All
men with recognized CF underwent genetic counselling.
Paternity in CF is a realistic option. Mean age at paternity in CF is comparable to
that of Italian healthy men (34.9 yrs). A great effort has to be made to diagnose CF
in adult to counsel about risks of transmitting CF.
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Objectives: The purpose of this study was to evaluate the baseline association
between demographic and regimen characteristics and nonadherence among teens
enrolled in the iCARE trial.
Methods: 597 adolescents with CF [age M=14.6 (SD= 2.6); 46% male; 89% white;
FEV1pp M=85% (SD= 22%)] completed a baseline visit; to-date we have baseline
pharmacy reﬁll data for 239. Participants’ caregivers provided demographic infor-
mation while the care team provided the prescribed regimen. A medication posses-
sion ratio (MPR) was calculated for each prescribed pulmonary medication (dornase
alpha, hypertonic saline, inhaled tobramycin, and azithromycin) and averaged to
create an Overall MPR. The odds of having an Overall MPR <0.50 were calculated
for each variable, and then controlling for all other variables.
Results: Overall Median MPR was 0.54 (IQR= 0.41, 0.72). No demographic vari-
able (age, gender, race/ethnicity (white/nonwhite), household income (<US$40,000,
$40–99,999, >$100,000), and insurance (private/public) was associated with having
an MPR <0.50. Having more pulmonary medicines prescribed was associated
with better adherence to those drugs. Compared to having only one pulmonary
medication prescribed and after controlling for other variables, the odds of having
an MPR <0.50 were 0.45 (95%CI: 0.22, 0.90) for being prescribed 2 drugs, 0.21
(95%CI: 0.10, 0.46) for 3 drugs and 0.10 (95%CI: 0.03, 0.31) for 4 drugs.
Conclusions: Demographic variables cannot be used to identify nonadherent pa-
tients. Other factors, such as depression and health beliefs, should be examined in
CF. Further examination of this non-intuitive ﬁnding that a more complex regimen
is associated with better adherence is needed.
331 CF and pain: a hidden complication?
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Objectives: This review aimed to evaluate research on pain in cystic ﬁbrosis.
Method: All papers in the English language studying pain in cystic ﬁbrosis (CF),
published between January 2000 and December 2011 were included. The review
focussed on incidence, duration, intensity and sites of pain, patients’ actions when
in pain, burden of pain and impact on quality of life (QoL).
Results: Nine papers were identiﬁed. The study populations were adults (n = 4),
children (n = 1) or combined (n = 4). Sites of pain reported were chest, head, neck,
abdomen, stomach, back and joints. Main difference between child and adult patient
was location, with children reporting more abdominal pain. Prevalence and duration
of pain ranged considerably, e.g. 6−55.5% daily or 1 hour to months. Intensity
ranged from ‘not upsetting’ to ‘severe pain’. Patients reported several actions
taken, most common was ‘analgesics by self-medication’. The majority of patients
did not report pain unless asked. Pain restricted patients in their activities (social,
work/school, relational), in their CF self-care and pain had an impact on QoL.
Recent studies reported a signiﬁcant association between pain, disease severity and
exacerbations.
Conclusions: Results of pain research are difﬁcult to evaluate because of the
variability in methods and measures. Studies to date indicate that pain is a main
burden, even in relatively healthy patients, yet few mention their pain without
prompting. Patients with more pain report a reduced QoL and more exacerbations.
Pain seems to affect patients’ ability to adhere to treatment. Pain should be
considered a common complication in CF and guidelines for treatment are needed.
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Background: Although no higher rates of eating disorders have been found in
cystic ﬁbrosis compared to the general population, studies have shown disturbed
eating attitudes and behaviour are present in the CF population and may contribute
to their poor nutritional status. CF patients who undergo a lung transplant may be
at an even higher risk of disturbed eating attitudes and behaviour secondary to a
multitude of factors.
Objectives: To determine the prevalence of disordered eating attitudes and be-
haviour in the CF lung transplant population. A secondary objective is to determine
whether other factors (age, gender, FEV-1, BMI, use of prednisone, etc.) are asso-
ciated with disturbed eating attitudes and behaviour. Thirdly, with our UK afﬁliates,
we are working to help validate a tool they have created speciﬁc to CF patients −
the Cystic Fibrosis Eating Attitudes and Behaviour Questionnaire (CFEAB).
Methods: 15 adult CF lung transplant (CF-LT) patients were recruited as well as
105 general CF patients to help with validation. 15 patients were also recruited
from the outpatient eating disorders program and the renal transplant clinic to act
as controls. All groups were given three questionnaires: a demographics form, the
Eating Disorders Examination Questionnaire-6 (EDE-Q6) and the CFEAB.
Conclusions: Our preliminary results indicate there is no statistical difference
between the CF and CF-LT group’s score on the EDE-Q6 and CFEAB. However, on
the EDE-Q6 a larger percentage of the CF group demonstrated eating disordered
attitudes and behaviour compared to the CF-LT group. On the CFEAB, a larger
percentage of the CF-LT group demonstrated pathology compared to the CF group.
